Myricx Bio Is A Uk Based Biotechnology Company Focused On Discovering And Developing Novel Payloads For Antibody Drug Conjugatesadcs Thecompany Specializes In Inhibitors Ofnmyristoyltransferasesnmt Which Areessential For Cancer Cell Survivalmyricx Bio Aims To Address Unmet Needs In Oncology By Advancing A Pipelineof Adcs That Utilizeits Nmt Inhibitor Payload Chemistry Platform Founded By Profed Tatedrroberto Solariand Drandrew Bellmyricx Bio Has Evolved From A Virtual Company Into A Fully Operational R&D Organization With Its Own Laboratoriesthecompany Is Headquartered In Londonwith Connections To Imperial Collegelondon And Thefrancis Crick Institutemyricx Bio Has Secured Significant Investmentincluding A A 90 Million Series A Financing Roundto Support Its Clinical Development Effortsthecompany Has Also Formed Strategic Partnershipsincluding An Exclusiveantibody Licenseagreement With Wuxi Biologicsto Enhanceits Capabilities In Adc Development
